# FDA Inspection 1209017 - Rxhomeo Private Limited - May 19, 2023

Source: https://www.keypedia.com/records/fda_inspections/rxhomeo-private-limited/6009c9a7-c364-46c1-bb05-fe73de6394c6
Source feed: FDA_Inspections

> FDA Inspection 1209017 for Rxhomeo Private Limited on May 19, 2023. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1209017
- Company Name: Rxhomeo Private Limited
- Inspection Date: 2023-05-19
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/rxhomeo-private-limited/b62358de-da81-47bc-b931-127955ac12cb

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c